REFERENCES
- Mandal A K, Lyden T W, Saklayen M G. Heparin lowers blood pressure: biological and clinical perspectives. Kidney Int.. 1995; 47: 1017–1022. [PUBMED], [INFOTRIEVE]
- Nelson R M, Cecconi O, Roberts W G, Aruffo A, Linhardt R J, Bevilacqua M P. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood.. 1993; 82: 3253–3258. [PUBMED], [INFOTRIEVE]
- Fedarko N S, Ishihara M, Courad H E. Control of cell division of hepatoma cells by exogeneous heparin sulfate proteoglycan. J Cell Physiol.. 1989; 139: 287–294. [PUBMED], [INFOTRIEVE]
- Reilly C F, Fritze L MS, Rosenberg R D. Heparin inhibition of smooth muscle cell proliferation: a cellular site of action. J Cell Physiol.. 1986; 129: 11–19. [PUBMED], [INFOTRIEVE]
- Erduran E, Tekelioğlu Y, Gedik Y, Yıldıran A. Apoptotic effects of heparin on lymphoblasts, neutrophils and mononuclear cells: results of a preliminary in vitro study. Am J Hematol.. 1999; 61: 90–93. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Manaster J, Chezar J, Schurtz-Swirski R, Shapiro G, Tendler Y, Kristal B, Shasha S M, Sela S. Heparin induces apoptosis in human peripheral blood neutrophils. Br J Haematol.. 1996; 94: 48–52. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Castellot J, Wong K, Herman B, et al, Binding and internalization heparin by vascular smooth muscle cell. J Cell Physiol.. 1985; 124: 13–20. [PUBMED], [INFOTRIEVE]
- Strasser A, O’Conner L, Dixit V M. Apoptosis signaling. Annu Rev Biochem.. 2000; 69: 217–245. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Alnemri E S, Livingstone D J, Nicholson D W, et al, Human ICE/CED-3 proteas nomenclature. Cell.. 1996; 87: 171, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nicholson D W, Thornberry N A. Caspases: killer proteases. Trends Biochem Sci.. 1997; 22: 299–306. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Thornberry N A, Lazebnik Y. Caspases: enemies within. Science.. 1998; 281: 1312–1316. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wickremasinghe R G, Hoffbrand A V. Biochemical and genetic control of apoptosis: relevance to normal hematopoiesis and hematological malignancies. Blood.. 1999; 93: 3587–3600. [PUBMED], [INFOTRIEVE]
- Chinnaiyan A M, O’Rourke K, Tewari M, Dixit V M. FADD, a novel death domain-containing protein, interact with the death domain of fas and initiates apoptosis. Cell.. 1995; 81: 513–523. [CROSSREF]
- Monaghan P, Robertson D, Amos T A, Dyer M J, Mason D Y, Greaver M F. Ultrastructural localization of bcl-2 protein. J Histochem Cytochem.. 1992; 40: 1819–1825. [PUBMED], [INFOTRIEVE]
- Green D R, Reed J C. Mitochondria and apoptosis. Science.. 1998; 281: 1309–1312. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Saunders B D, Trapp R G. Decisions about two independent groups. Basic and Clinical Bioistatistics, ed. 2, London, Prentice-Hall. 1994; 112–119
- Ormerod M G. The study of apoptotic cells by flow cytometry. Leukemia.. 1998; 12: 1013–1025. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Daryzynkiewicz Z, Bruno S, Del Bino G, Hotz M A, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry.. 1992; 13: 795–808
- Kerr J FR, Wyllie A H, Currie A R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer.. 1972; 26: 239–257. [PUBMED]
- Fleisher T A. Apoptosis. Ann Allergy Asthma Immunol.. 1997; 78: 245–250. [PUBMED], [INFOTRIEVE]
- Cohen G M, Sun X M, Snowden R T, Dinsdale D, Skilleter D N. Key morphological features of apoptosis may occur in the abscence of internucleosomal DNA degradation. Biochem J.. 1992; 286: 331–334. [PUBMED], [INFOTRIEVE]
- Nagata S, Golstein P. The fas death factor. Science.. 1995; 267: 1449–1456. [PUBMED], [INFOTRIEVE]
- Munker R, Lubbert M, Yonehara S, Tuchnitz A, Wilmanns W. Expression of the fas antigen on primary human leukemia cells. Ann Hematol.. 1995; 70: 15–17. [PUBMED], [INFOTRIEVE]
- Robertson M J, Manley T J, Pichert G, Cameron C, Levine H, Ritz J. Functional consequences of APO-1/fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk Lymphoma.. 1995; 17: 51–61. [PUBMED]
- Debatin K M, Krammer P H. Resistance to APO-1 (CD95) induced apoptosis in T-ALL determined by a bcl-2 independent anti-apoptotic program. Leukemia.. 1995; 9: 815–820. [PUBMED]
- Baryshnikov A, Polosukhina E R, Tupitsin N N, et al, CD95 (fas/APO-1) is a new prognostic marker for blast cells of acute lymphoblastic leukaemia patient. Adv Exp Med Biol.. 1999; 457: 251–258. [PUBMED], [INFOTRIEVE]
- Beltinger C, Bohler T, Karawajew L, Ludwig W D, Debatin K M. Mutation analysis of CD95 (APO-1/fas) in childhood B lineage acute lymphoblastic leukaemia. Br J Haematol.. 1998; 102: 722–728. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Barcena A, Park S W, Banapour B, Muench M O, Mechetner E. Expression of fas/CD95 and bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood.. 1996; 88: 2013–2025. [PUBMED], [INFOTRIEVE]
- Karawajew L, Wuchter C, Ruppert V, Drexler H, Gruss H J, Ludwig W D. Differential CD95 expression in T and B lineage acute lymphoblastic leukemia cells. Leukemia.. 1997; 11: 1245–1252. [PUBMED], [INFOTRIEVE], [CROSSREF]